Actively Recruiting
Non-invasive Tools for PSVD Diagnosis
Led by Nanfang Hospital, Southern Medical University · Updated on 2024-07-15
1000
Participants Needed
1
Research Sites
304 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Patients treated with platinum-based chemotherapy drugs have the probability of developing PSVD. The diagnosis of PSVD depends on liver biopsy. In addition, the level of portal vein pressure has guiding value in the diagnosis and prognosis of PSVD. Many studies have shown that liver and spleen stiffness have high accuracy in diagnosis and prognosis. The purpose of this study is to evaluate the efficacy of the combination of liver and spleen stiffness in the diagnosis of PSVD and to search for effective biomarkers for the diagnosis of PSVD through a single-center, prospective, observational study.
CONDITIONS
Official Title
Non-invasive Tools for PSVD Diagnosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Received platinum chemotherapy for organ tumors
- Aged between 18 and 80 years
- Signed informed consent voluntarily
You will not qualify if you...
- Liver pathology showing cirrhosis
- History of liver transplantation
- Hepatocellular carcinoma exceeding Milan criteria
- Severe heart, kidney, or lung failure
- Pregnant or lactating women
- Serious missing data
- Judged unsuitable for participation by researchers
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Nanfang hospital, Southern Medical Uiversity
Guangzhou, Guangdong, China, 510080
Actively Recruiting
Research Team
X
Xiaofeng Zhang
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here